European Patients Forum, logo.

EPF's EU Elections campaign 2024

Towards a truly participatory, democratic, and impactful involvement of patient organisations

Amplifying Patient Advocacy on Antimicrobial Resistance (AMR)

Understanding Antimicrobial Resistance (AMR) and its impact on patients. The AMR Info Point is dedicated to providing extensive resources on AMR. Our goal is to improve awareness and understanding of AMR among patient communities.

HTA Info Point

Patient Involvement in Health Technology Assessment (HTA)

Health Technology Assessment (HTA) is a systematic evaluation process used to assess the properties, effects, and impacts of health technology. This includes not just medical devices and equipment, but also drugs, medical procedures, and broader healthcare policies and systems.

Knowledge Hub on Artificial Intelligence in Healthcare

The AI Knowledge Hub is dedicated to help patient organisations and other interested stakeholders to better engage in debates, projects and initiatives on AI in healthcare, both at national and European levels.

WHAT WE DO

Policy and advocacy, icon

Policy and advocacy

EPF is active in a number of policy areas to ensure that patients' views are incorporated into the EU policy agenda. We develop campaign and advocacy strategies

Projects icon

Projects

EPF has been active in various health-related EU projects over the past few years both as a leader or associate partner to gather patient-related evidence based information

Capacity building icon

Capacity building

The Capacity Building Programme was designed in 2012 to respond to needs and concerns which have been identified by our membership during previous activities of EPF.

NEWS AND UPDATES

09/09/24 EVENTS PATIENT EMPOWERMENT PATIENT INVOLVEMENT

Empowering Patients in HTA: Joint Initiative by OPEN Health, EPF, and EAMDA to Optimise PICO Scoping

From 12 January 2025, the new EU regulation on Health Technology Assessment (HTAR) will significantly shift how health technologies are evaluated across Europe. This regulation introduces a more structured and standardised approach to HTA,

28/06/24 EVENTS PATIENT EMPOWERMENT PATIENT INVOLVEMENT

EPF’s analysis of the European Parliament reports on the revision of the EU pharmaceutical legislation

On 10 April 2024, the European Parliament adopted the reports on the Directive and the Regulation, thus formalising the Parliament's official position on the revision of the EU pharmaceutical legislation. The reports of the European Parliament

05/08/24 EVENTS PATIENT EMPOWERMENT PATIENT INVOLVEMENT

Call for Patients EDiHTA

Call for patients – EDiHTA project : European Digital Health Technology Assessment framework

Visit the newspage

Upcoming events

Visit the Events page

Interested in becoming a member?

As your advocate, EPF provides many benefits to its members. We represent our members' voice at the European level on cross-cutting health issues.

Our team